HD-OPM Archive
Topics › Insulin resistance & diabetes

Taurine 3 g/day lowered insulin, HOMA-IR and inflammation in type 2 diabetes RCT

Louis Nervegna · Jul 04, 2026 · ♥ 22 reactions · 15 comments · original Facebook post
Insulin resistance & diabetesSupplements & vitaminsInflammation & CRP
AI summary & key facts

A 120-person RCT gave 3 g taurine daily with a low-calorie diet for 8 weeks. Insulin, HOMA-IR, TNF, hs-CRP and MDA fell, but lipids, HbA1c and fasting glucose did not improve.

Taurine supplementation lowers fasting insulin and HOMA-IR, and improves markers of inflammation and endothelial disfunction.

This was in type 2 diabetics.

Link to full study:

Paper · Nutr Metab (Lond) · 2022Protective and therapeutic effectiveness of taurine supplementation plus low calorie diet on metabolic parameters and endothelial markers in patients with diabetes mellitus: a randomized, clinical trial.Conclusion: The evidence from our study revealed that Taurine supplementation significantly reduced insulin and HOMA-IR, as well as oxidative stress, inflammation, and endothelial markers in individuals with T2DM. Trial registration The protocol of the study was recorded in the Iranian Registry of Clinical Trials (IRCT20180712040438N3).pmc.ncbi.nlm.nih.gov

Quoted:

“After 8 weeks, Taurine-supplemented patients had a considerable decrease in serum insulin and HOMA-IR compared to placebo group. However, Taurine supplementation did not improve other metabolic parameters including lipid profiles, glycated hemoglobin, and fasting blood glucose (FBG). There was a significant decline in MDA, TNF, and hs-CRP levels after these eight-week period of Taurine supplementation. In addition, the Taurine group had fewer serum levels of endothelial dysfunction markers than the placebo group [indicating improved endothelial function].”

My note:

I previously posted about a small randomized trial showing two weeks of taurine supplementation (1.5g/day) reversed early endothelial disfunction in young men with type 1 diabetes, improving blood vessel function. See this post:

↪ Taurine 1.5 g/day for 2 weeks reversed endothelial dysfunction in type 1 diabetes

For summaries of the effects of taurine on various cardiometabolic risk factors, see these posts:

↪ Taurine lowered blood pressure, LDL, glucose and insulin resistance in a meta-analysis

↪ Meta-analysis of 34 RCTs: taurine supplements improved several cardiometabolic markers

↪ Gokhan's review of taurine's anti-inflammatory effects in cardiovascular disease

#taurineHD #insulinHD #homairHD #insulinresistanceHD #endotheliumHD #diabetesHD #tnfalphaHD #hscrpHD

Research cited

In a randomized clinical trial published in the journal Nutrition & Metabolism in 2022, 120 people with type 2 diabetes were divided into two groups while following a low-calorie diet. One group of 60 people took 1 gram of taurine three times a day—a total of 3 grams daily—for 8 weeks, while the other 60 received a placebo. Researchers measured insulin resistance, blood sugar, cholesterol, oxidative stress, inflammation markers, and markers of blood-vessel dysfunction.

After 8 weeks, people taking taurine had lower insulin levels and improved insulin resistance, measured using HOMA-IR. Taurine also reduced the inflammation markers TNF and hs-CRP, the oxidative stress marker MDA, and the blood-vessel dysfunction markers ICAM-1, VCAM, and MMP-9 compared with the placebo group. However, taurine did not significantly improve fasting blood sugar, HbA1c, cholesterol, or triglycerides, showing that its strongest effects in this study were on insulin resistance and markers linked to inflammation, oxidative stress, and blood-vessel health.

PMID: 35870947
PMCID: PMC9308194

No photo description available.
← newer: Gokhan's review of taurine's anti-inflammatory effects in caolder: Gel, feed and sweep: why the word 'fiber' on a label says li →